Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC label format up to professionals, not consumers -- NDMA on FDA's "Study B".

This article was originally published in The Tan Sheet

Executive Summary

OTC LABEL ACTUAL USE "MORE IMPORTANT" THAN CONSUMER PREFERENCE in evaluating appropriate format and contents of labeling, the Nonprescription Drug Manufacturers Association says in Feb. 13 comments to FDA. The comments address results of the agency's OTC Label Format Preference, "Study B," which were posted on FDA's Web site in late December and are expected to be factored into the agency's final rule on OTC labeling. FDA published a proposed rule on OTC label reform nearly a year ago ("The Tan Sheet" March 3, 1997, pp. 1-9).
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088128

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel